While upper-tract transitional cell carcinoma (TCC) accounts for only 5% of urothelial malignancies, evidence suggests that the frequency of these lesions is increasing Radical nephroureterectomy ...

Advanced transitional-cell carcinoma ... of bladder cancer is also discussed, as are future perspectives and a five-year view in the treatment of the disease in patients with renal impairment.

Instead, transitional cell carcinoma starts in your renal pelvis, the top part of your ureter. Your ureter is the tube that ...

(Pembrolizumab + vibostolimab) is under clinical development by Merck and currently in Phase II for Metastatic Colorectal Cancer.

Catequentinib hydrochloride is under clinical development by Advenchen Laboratories and currently in Phase II for Non-Small Cell Lung Cancer.